Aids-associated vacuolar myelopathy and tumor necrosis factor-alpha (TNFα)

[1]  F. Scaravilli,et al.  AIDS-associated vacuolar myelopathy. A morphometric study. , 1995, Brain : a journal of neurology.

[2]  C. Raine,et al.  The adhesion molecule and cytokine profile of multiple sclerosis lesions , 1995, Annals of neurology.

[3]  Yao-Tseng Chen,et al.  HIV Antigen and DNA in AIDS Spinal Cords Correlate with Macrophage Infiltration but not with Vacuolar Myelopathy , 1993, Journal of neuropathology and experimental neurology.

[4]  J. Glass,et al.  Cytokine expression of macrophages in HIV‐1‐associated vacuolar myelopathy , 1993, Neurology.

[5]  M. Bergmann,et al.  AIDS-Myelopathy , 1993, Pathology - Research and Practice.

[6]  S. Lederman,et al.  The gp120 glycoprotein of HIV‐1 binds to sulfatide and to the myelin associated glycoprotein , 1992, Journal of neuroscience research.

[7]  J. Hauw,et al.  Neuropathology of the spinal cord in the acquired immunodeficiency syndrome. , 1992, Human pathology.

[8]  V. Vullo,et al.  Tumour necrosis factor (TNF-alpha) and neurological disorders in HIV infection. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[9]  M. Sharief,et al.  Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis , 1991 .

[10]  D. Dickson,et al.  Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. , 1991, Human pathology.

[11]  D. Weir,et al.  Evidence of brain methyltransferase inhibition and early brain involvement in HIV-positive patients , 1991, The Lancet.

[12]  C. Brosnan,et al.  Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. , 1991, The Journal of clinical investigation.

[13]  R. Schiffer,et al.  Abnormal vitamin B12 metabolism in human immunodeficiency virus infection. Association with neurological dysfunction. , 1991, Archives of neurology.

[14]  J. Sidtis,et al.  Quinolinic acid in cerebrospinal fluid and serum in HIV‐1 Infection: Relationship to clinical and neurological status , 1991, Annals of neurology.

[15]  D. Giulian,et al.  Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1 , 1990, Science.

[16]  K. Hyland,et al.  Cerebrospinal fluid concentrations of S-adenosylmethionine, methionine, and 5-methyltetrahydrofolate in a reference population: cerebrospinal fluid S-adenosylmethionine declines with age in humans. , 1990, Biochemical medicine and metabolic biology.

[17]  L. Epstein,et al.  Spinal cord disease in children with HIV‐1 infection: a combined molecular biological and neuropathological study * , 1990, Neuropathology and applied neurobiology.

[18]  N. Peress,et al.  Human immunodeficiency virus type 1 expression in the central nervous system correlates directly with extent of disease. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Artigas,et al.  Vacuolar myelopathy in AIDS. A morphological analysis. , 1990, Pathology, research and practice.

[20]  K. Hyland,et al.  Central-nervous-system methyl-group metabolism in children with neurological complications of HIV infection , 1990, The Lancet.

[21]  J. Merrill,et al.  Tumor necrosis factor identified in multiple sclerosis brain , 1989, The Journal of experimental medicine.

[22]  M. Rosenblum,et al.  Dissociation of AIDS‐related vacuolar myelopathy and productive HIV‐1 infection of the spinal cord , 1989, Neurology.

[23]  C. Wiley,et al.  Spinal cord and peripheral nerve pathology in AIDS: The roles of cytomegalovirus and human immunodeficiency virus , 1989, Annals of neurology.

[24]  B. Tavolato,et al.  Tumor necrosis factor alpha (TNFα) and neurological diseases Failure in detecting TNFα in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex, and brain tumours , 1989, Journal of Neuroimmunology.

[25]  H. Gendelman,et al.  Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency syndrome patients with myelopathy: expression and replication in macrophages. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Price,et al.  The AIDS dementia complex. , 1988, The Journal of infectious diseases.

[27]  A. Cerami,et al.  Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses , 1988, The Journal of cell biology.

[28]  K. Selmaj,et al.  Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro , 1988, Annals of neurology.

[29]  T. Bottiglieri,et al.  Demyelination and decreased S‐adenosylmethionine in 5.10‐methylenetetrahydrofolate reductase deficiency , 1988, Neurology.

[30]  D. Newell,et al.  In pursuit of evidence based integrated care , 1987, British Journal of Cancer.

[31]  B. Navia,et al.  Neuropathology of Acquired Immunodeficiency Syndrome (AIDS): An Autopsy Review , 1986, Journal of neuropathology and experimental neurology.

[32]  B. Navia,et al.  The AIDS dementia complex: II. Neuropathology , 1986, Annals of neurology.

[33]  B. Navia,et al.  Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. , 1985, The New England journal of medicine.

[34]  R. Colvin,et al.  The immunopathology of experimental allergic encephalomyelitis. I. Quantitative analysis of inflammatory cells in situ. , 1984, Journal of immunology.

[35]  J. Riancho,et al.  Age-related differences in cytokine secretion. , 1994, Gerontology.

[36]  R. Rhodes,et al.  Immunohistochemical localization of human immunodeficiency viral antigens in formalin-fixed spinal cords with AIDS myelopathy. , 1989, Clinical neuropathology.